There’s only one vaccine that has been approved by the Food and Drug Administration for the treatment of metastatic melanoma patients. Talimogene Laherparepvec (T-VEC) is a modified herpes virus that’s injected directly into the lesion and causes the death of cancer cells. It is approved for melanoma that cannot be surgically removed. There have been a number of studies of other potential melanoma treatments, but so far none have been successful.
There have been many developments in recent years when it comes to treating melanoma, but there is no one-size-fits-all approach to this disease. Doctors have a handful of tools to choose from, and many factors will go into determining your treatment.
Immunotherapy for melanoma does often work well–but the side effects do need to be considered.
Immunotherapy Helps Your Body Help Itself
Immunotherapy for Melanoma Can Work, but Side Effects are a Risk
Side Effects from Immunotherapy Can be Managed
Immunotherapy Needs to be Tailored
A Melanoma Vaccine for Metastatic Patients
Radiation is Effective for Certain Metastatic Melanoma Patients